SIBIA Neurosciences (SIBI) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SIBIA Neurosciences (SIBI)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (203)	7/31/1998 9:20:00 AM
From: scaram(o)uche	Read Replies (1) of 579

2nd quarter results are out, no surprises...... prnewswire.com "Looking ahead, we expect to accelerate our efforts and continue to leverage our unique drug discovery programs and technology platforms to attract major strategic collaborations with pharmaceutical and biotechnology companies." To me, that means not only 1508Y and 1553A, but also VGCC for migraine and other programs. Cognetix made a recent acquisition. I just checked my files, and I guess that I didn't copy the announcement. Did anyone else get a copy? Rick

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next